SQUAWK/NEWS
Account
Theme
Account
Menu
Live News NEWS FLASH L impact

PLRZ - Polyrizon Enrolls First Patient in U.S. Clinical Study of NASARIX (PL-14) Allergy Blocker

PLRZ